Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA (2010) J Clin Oncol 28: 1069-74 Intraoperative guidance for intrauterine procedures with transrectal sonography. Fleischer AC, Burnett LS, Murray MJ, Jones HW (1990) Radiology 176: 576-7 Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, Goto T, Omata M, Yoshida H, Koike K (2011) Cancer 117: 4475-83 Uterine Neoplasms. Clinical Practice Guidelines in Oncology. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos SM, Cho KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jaggernauth W, Kapp DS, Kavanagh JJ, Lurain JR, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W, Teng N (2009) J Natl Compr Canc Netw 7: 498-531 High dose endobronchial irradiation in recurrent bronchogenic carcinoma. Gauwitz M, Ellerbroek N, Komaki R, Putnam JB, Ryan MB, DeCaro L, Davis M, Cundiff J (1992) Int J Radiat Oncol Biol Phys 23: 397-400 Studies with encapsulated 125I sources. I. Apparatus and dosimetry for determination of relative biological effectiveness. Goldhagen PE, Freeman ML, Hall EJ (1982) Int J Radiat Oncol Biol Phys 8: 1347-53 Studies with encapsulated 125I sources. II. Determination of the relative biological effectiveness using cultured mammalian cells. Freeman ML, Goldhagen P, Sierra E, Hall EJ (1982) Int J Radiat Oncol Biol Phys 8: 1355-61 Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy. Brantley MA, Worley L, Harbour JW (2002) Am J Ophthalmol 133: 242-8 Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ (2002) Am J Ophthalmol 133: 657-64 The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial. Fernando HC, Landreneau RJ, Mandrekar SJ, Hillman SL, Nichols FC, Meyers B, DiPetrillo TA, Heron D, Jones DR, Daly BD, Starnes SL, Hatter JE, Putnam JB (2011) J Thorac Cardiovasc Surg 142: 554-62 Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. Fernando HC, Landreneau RJ, Mandrekar SJ, Hillman SL, Nichols FC, Meyers B, DiPetrillo TA, Heron DE, Jones DR, Daly BD, Starnes SL, Tan A, Putnam JB (2011) J Thorac Cardiovasc Surg 142: 1143-51 Trends in the treatment of localized prostate cancer using supplemented cancer registry data. Hamilton AS, Albertsen PC, Johnson TK, Hoffman R, Morrell D, Deapen D, Penson DF (2011) BJU Int 107: 576-84 Radiation therapy dosimetry using magnetic resonance imaging of polymer gels. Maryanski MJ, Ibbott GS, Eastman P, Schulz RJ, Gore JC (1996) Med Phys 23: 699-705 Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions. Ramsey SD, Zeliadt SB, Fedorenko CR, Blough DK, Moinpour CM, Hall IJ, Smith JL, Ekwueme DU, Fairweather ME, Thompson IM, Keane TE, Penson DF (2011) World J Urol 29: 3-9 Magnetic resonance imaging of radiation dose distributions using a polymer-gel dosimeter. Maryanski MJ, Schulz RJ, Ibbott GS, Gatenby JC, Xie J, Horton D, Gore JC (1994) Phys Med Biol 39: 1437-55 A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone. Papagikos MA, Rossi PJ, Urbanic JJ, deGuzman AF, McCullough DL, Clark PE, Lee WR (2007) Am J Clin Oncol 30: 199-204 Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer. Rossi PJ, Clark PE, Papagikos MA, McCullough DL, Lee WR (2006) Urology 67: 349-53 Multiple simultaneous choroidal melanomas arising in the same eye: globe salvage by radiotherapy. Zhang MM, Papakostas TD, Malcolm AW, Ancell KK, Biscotti CV, Gragoudas ES, Daniels AB (2016) Acta Ophthalmol 94: e799-e802 Localized hyperthermia with iron oxide-doped yttrium microparticles: steps toward image-guided thermoradiotherapy in liver cancer. Gordon AC, Lewandowski RJ, Salem R, Day DE, Omary RA, Larson AC (2014) J Vasc Interv Radiol 25: 397-404 Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M (2007) J Vasc Interv Radiol 18: 553-61; quiz 562 Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes. Piana PM, Bar V, Doyle L, Anne R, Sato T, Eschelman DJ, McCann JW, Gonsalves CF, Brown DB (2014) HPB (Oxford) 16: 336-41 Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone. Rossi PJ, Urbanic J, Clark PE, McCullough DL, Lee WR (2008) Brachytherapy 7: 286-9 Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)? Papagikos MA, Deguzman AF, Rossi PJ, McCullough DL, Clark PE, Lee WR (2005) Brachytherapy 4: 252-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.